XML 47 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Collaboration Agreements - Schedule of Significant Changes in Deferred Revenue Balances, Antibody Collaboration (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Disaggregation of Revenue [Line Items]    
Increase (decrease) in deferred revenue $ (29,462) $ (59,116)
Sanofi Collaboration Agreement, Antibody    
Disaggregation of Revenue [Line Items]    
Increase (decrease) in deferred revenue 178,608  
Revenue recognized that was included in deferred revenue at the beginning of the period $ (96,767)